Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,227 public trials 1,016 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

NCT04330664

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Local Institution - 002-805 Los Angeles, California, United States
  • Local Institution - 002-803 Orange, California, United States
  • Local Institution - 002-828 Chicago, Illinois, United States
  • Local Institution - 002-942 Wichita, Kansas, United States
View all 17 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other Diseases

NCT03389399

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Colorado Denver Aurora, Colorado, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • UT Southwestern Harold C Simmons Comprehensive Cancer Center Dallas, Texas, United States
View Trial Details
Completed

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

NCT03631784

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St Joseph Heritage Healthcare ( Site 1403) Santa Rosa, California, United States
  • North Shore University Health System ( Site 1413) Evanston, Illinois, United States
  • Parkview Cancer Institute ( Site 1415) Fort Wayne, Indiana, United States
  • UMass Memorial Medical Center ( Site 1417) Worcester, Massachusetts, United States
View all 56 locations
View Trial Details
Completed

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

NCT03046992

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • The Catholic University of Korea, Bucheon St. Mary's Hospital Bucheon-si, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View all 16 locations
View Trial Details

Related conditions